Scancell Share Discussion Threads

[tosh123] 23/1/2019 09:01

Heres an idea, not saying that it will happen, but its maybe a possibility.

Modi will be hived off into a separate collaboration company with a third party / parties, who will fund the research and trials eg ;- the project blue print team.
The new company will be part owned by all the collaborators ( including Scancell ).

The SCIB technology will remain 100% owned by Scancell.

From memory, i think it was DE who stated many years ago, that we were spreading ourselves too thinly, and should focus our efforts on one platform rather than trying to develop numerous.

[the real lozan] 23/1/2019 08:54

goosed et al -
" yes, not long to wait for interims. Cash position and maybe a bit of info on other areas."
Indeed the interims are due
However -
Those figs will ONLY reveal the situation as of End OCT 2018 = Already 'out-of-date'
The REAL situation will not be revealed { Although there is little doubt that Nanny'n'co will CONtinue to present more FALSE ones in the meantime} ...until full-year-end results ..set to be published circa End SEPT 2019
.
What HAS been CLEARLY revealed by the CRUK result is =
Just how dangerous the BUY,BUY,BUY SCAM gang are / have been for 7 YEARS
7 YEARS of LIES, FALSE CLAIMS = 7 YEARS of LOSSES {With more to come}
.
At least - some are NOW listening to reason/common sense

[gazza] 23/1/2019 08:42

I'm afraid Ray pointless does wind me up with his complete drivel sometimes!

[tosh123] 23/1/2019 08:34

and yet another pearl of wisdom from the idiot... " Calm down Mr Ivy ... the share price moved because of the RNS about the way scancell is forging ahead on its existing collaborations and trials by hiring highly skilled staff "

No it didnt, i moved on the expectation of us winning the GC, its absolutely obvious.

We didnt get the award, but the new staff are still in post, and the share price dropped nearly 20%.
This not only suggests, it CONFIRMS that the rise was due to the potential GC award.

Nothing else has changed... idiot !

[tosh123] 23/1/2019 08:30

Ruckrover... talking total sense, in a whirlpool of absolute nonsense on the other place.

[bermudashorts] 23/1/2019 08:30

Yes certainly buried in the RNS was indirect confirmation that cash will be needed to even start Modi1 trial - can only hope it comes from BioNtech deal.

miavoce - we'll probably never know but I think more likely is that the project was too commercial for CRUK. The whole point of the Grand Challenge is that it tackles big problems at a very high level that are unlikely to be tackled by industry. They're very clear that it's not there for product development for industry and with 3 members of the team already having licensing deals/collaborations in place perhaps that's how they saw PBP.

Can only hope good news comes soon from other sources - IND for SCIB1 would be a good place to start:)

[tosh123] 23/1/2019 08:27

Miavoce,
that is exactly what a few of us have been saying for quite a while eg ;- just because it works on mice does not mean it will automatically work in humans.
The RISKS are very real, this is a high risk investment, countered by potentially very high rewards, but we're still very much in the RISK phase of the investment, as born out by the share price
Other idiots can try to tell everyone that this is a foregone, but ALL THE FACTS state differently.

Listen to the uneducated ramblings of a proven liar and cheat, at your peril.

There is still a long way to go before this starts to get derisked.. a long long way.

[miavoce] 23/1/2019 08:20

I suspect that had Moditope been proven in humans it would have been a different story, but without that this would have been a high risk award for CRUK to make.

[tosh123] 23/1/2019 08:18

Berm,
theres a world of difference between thinking ( hoping ) that we would be successful, and promoting the notion that it is already " in the bag ".
I was also very hopeful, however, the addition of the new recruits this week somewhat poured cold water on my optimism, it just didnt make sense, unless they were preparing for something other than a GC win, hence my comment about a " near term " funding option.
Contrary to what the caped crusader preaches, unfortunately more cash will be needed, and pretty soon, so im hoping that there is a plan B and that it will be announced before the share price takes too much of a hammering.
I point my finger at specific individuals, who continuously LIE and HYPE.
They call everything wrong and mislead so many people, one in particular is very dangerous.

[gooosed] 23/1/2019 08:15

Bs - yes, not long to wait for interims. Cash position and maybe a bit of info on other areas.

[oldnotwise] 23/1/2019 08:15

Berm
I think the GC result is sad in that I agree with your 18979, but the award would have been a massive accolade but it doesn't (in my view) spell disaster.
Whether anyone called it right or wrong is immaterial, its more to do with HOW it was called so no holding hands up!!
What it does do is focus the mind on what happens next and we all know (or think we do) what the short term plan is.
Maybe there's a good reason for the award not coming our way.... (don't forget the delay in the announcement).
AIMO
ATB

[oldnotwise] 23/1/2019 08:08

So, the GC "win" wasn't priced in? LOL
ATB

[bermudashorts] 23/1/2019 08:07

Tosh, have to admit that I was one of those who believed PBP would receive an award based on the calibre of the team and the aim of the project - have to hold my hands up and admit I called it wrong.

There is no dressing this up as good news and I thought Scancell hit the right note with the RNS this morning - hope they just leave it at that.

[oldnotwise] 23/1/2019 08:06

I think I've seen it all now, where someone says that CRUK didn't look on PBP as pure research. Since they shortlisted Scancell's (or at least the collaborative group's) submission for the GC I don't quite follow the "reasoning".
Anyway, the guaranteed £20M isn't forthcoming and that's reflected in the opening price this morning.
CRUK continue to be a major force in Global Cancer research, and I for one trust their judgement even though it's not apparently in Scancell's favour this time.
As Berm says, Scancell's RNS this morning is one of the better pieces of communication from the company in the manner in which it's presented, when dealing with a difficult topic.
AIMO
ATB

[plasybryn] 23/1/2019 07:53

We had great publicity. Microbiome developments are very early stage but incredibly exciting. Our gut appears to play centre stage to so much of our well being. Good luck to the winner.

[tosh123] 23/1/2019 07:35

A very sad day im afraid, made even more devastating by the endless claims that we had it in the bag, from certain idiots.
Now it would appear that our science is far too well developed for CRUK already !!! You honestly couldn't make this stuff up, what absolute pony.
The village idiot also now goes into reverse gear by stating that he thought our submission may fail... WHAT ??? The liar !
The problem is, none of the happy clappers are businessmen, or have any grasp of how business works. The first rule is that you make no assumptions, you deal in facts, NOT fantasy.
The facts of the matter are, that until today, there has not been a queue of Bio's looking to fund or JV with Scancell.

I take no pleasure in the fact that we are once again back to square one and the topic of funding is now top of the agenda.
Hopefully there will be a plan B, hence the new recruits, but history tells us that nothing should be taken for granted, especially in the realms of scientific discovery.
This IS a small bio, and with it comes HIGH RISK, let no idiot tell anyone anything different.
Yet more egg on the face of an already over egged caped crusader.
I repeat once again... The guy is a liar and a liability.

[bermudashorts] 23/1/2019 07:10

Yep great shame and disappointing - gracious RNS this morning from Scancell.

[plasybryn] 23/1/2019 01:30

https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2019-01-23-cancer-research-uk-tackles-global-cancer-challenges-with-ps60-million-in-funding

[bermudashorts] 22/1/2019 20:47

Thanks for that gooosed - wonder whether interims might give more clues.

[gooosed] 22/1/2019 20:02

a trusted source relayed a conversation with Alan Lewis at the AGM concerning new Lab(s) . . . . . on that basis it perhaps brings yesterdays RNSr into sharper focus :

"Based at the Company's corporate offices in Oxford, Samantha will report directly to Scancell's founder and Chief Scientific Officer"

"Adrian will also be based in the Oxford offices and will report to Dr Sally Adams"

[funtimejonny] 22/1/2019 19:28

Ah...a Spilling lesson!

[funtimejonny] 22/1/2019 18:54

Ah...a Spilling lesson!

[drdobson1] 22/1/2019 18:31

Thank you for spilling lesson.
Don’t make comments like looking a bit toppy on MFFF or Professor PLUM will give you a Maths Lesson.
£20 a share and NO RISK.Well will see if we win tonite rather than HAVE WON already OPINED by the trHYPE swallowers

[funtimejonny] 22/1/2019 17:38

Learn to spell EDUCATION before slagging others off for lack of it!